Komipharm International Co., Ltd. (KOSDAQ:041960)

Komipharm International Revenue

Komipharm International had revenue of 11.94B KRW in the quarter ending March 31, 2026, a decrease of -17.15%. This brings the company's revenue in the last twelve months to 49.99B, down -17.08% year-over-year. In the year 2025, Komipharm International had annual revenue of 52.47B, down -10.74%.

• Revenue (ttm): 49.99B
• Revenue Growth: -17.08%
• P/S Ratio: 12.39
• Revenue / Employee: 310.52M
• Employees: 161
• Market Cap: 619.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	52.47B	-6.31B	-10.74%
Dec 31, 2024	58.78B	16.13B	37.83%
Dec 31, 2023	42.65B	2.85B	7.15%
Dec 31, 2022	39.80B	3.95B	11.03%
Dec 31, 2021	35.85B	-1.31B	-3.53%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error